RecruitingNot applicableNCT06584045

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

Studying Autoimmune encephalitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tongji Hospital
Intervention
Calculus bovis sativus (CBS)(drug)
Enrollment
250 enrolled
Eligibility
18 years · All sexes
Timeline
20242029

Study locations (1)

Collaborators

Jianmin Pharmaceutical Group Co., LTD.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06584045 on ClinicalTrials.gov

Other trials for Autoimmune encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Autoimmune encephalitis

← Back to all trials